Omental Caking: Causes, Symptoms, and Treatment

Omental caking is a radiologic and surgical finding in which the omentum, a large apron-like fold of fatty tissue draped over the intestines, becomes diffusely thickened and hardened by disease. The term dates back to early 1900s surgical literature, and its most common cause by a wide margin is metastatic cancer, particularly ovarian carcinoma. While the finding itself is not a disease, its presence on imaging almost always signals an advanced abdominal condition that demands prompt workup and treatment.

What the Omentum Actually Does

Most people have never heard of the omentum, which is surprising given that it weighs up to a couple of pounds in adults and hangs like a curtain from the stomach and colon across the front of the abdomen. Far from being inert padding, the omentum is now recognized as an active immunologic organ with a complex structure suited for defending against pathogens and injury.¹ It contains dense networks of blood vessels and lymphatic channels, along with clusters of immune cells called milky spots that help clear infections, regulate inflammation, and assist in tissue repair.²

The milky spots act as immune gateways. They consist mainly of macrophages and lymphocytes, and they allow inflammatory cells to move between the omentum and the peritoneal cavity in response to infection or injury.¹ Surgeons have long observed that the omentum migrates toward sites of infection or surgical trauma, sometimes wrapping itself around inflamed organs. This immune-rich environment, ironically, is also what makes the omentum vulnerable to being hijacked by cancer.

Why Cancer Targets the Omentum

Metastatic cancer is the most common cause of omental caking.³ When cancerous cells break free from an abdominal tumor, they float through the peritoneal fluid that bathes the organs. The omentum’s milky spots, with their capillary networks designed to draw in cells from that fluid, inadvertently become landing pads for tumor cells. Research using experimental models has shown that ovarian cancer cells preferentially lodge and grow within omental fat that contains milky spots, rather than in peritoneal fat deposits that lack them. Growth medium conditioned by milky-spot-containing tissue caused roughly 75 percent more cancer cell migration than medium from tissue without milky spots.⁴ The very immune structures meant to protect the abdomen become hotbeds for cancer colonization.

Once tumor cells take hold in the omentum, the disease progresses in stages that show up on imaging. Early involvement appears as a smudged or hazy look in the normally clean omental fat. As disease advances, distinct soft tissue nodules form. Eventually these nodules coalesce into a single thick mass that replaces the normal fat entirely, and the omentum transforms from a barely visible fatty band into a bulky, solid sheet that can push the intestines away from the abdominal wall.³ That solid, cake-like mass is what clinicians refer to as an omental cake.

Which Cancers Cause Omental Caking

Ovarian carcinoma is the prototype. It is the single most common malignancy behind omental caking, and omentectomy became part of ovarian cancer treatment guidelines in the 1960s after surgeons noticed the omentum was a frequent site of spread and that removing all visible disease improved outcomes.⁵ But ovarian cancer is not the only culprit. Colorectal, pancreatic, and gastric cancers also commonly spread to the omentum. In reality, virtually any tumor capable of intraperitoneal spread, including endometrial and bladder cancers, can produce an omental cake.³

Less commonly, primary peritoneal cancers can be responsible. Malignant peritoneal mesothelioma, a rare and aggressive cancer, has been documented presenting with omental caking, large-volume ascites, and extensive peritoneal thickening that can closely mimic ovarian cancer with peritoneal spread.⁶ Pseudomyxoma peritonei, a condition in which mucin-producing tumors fill the abdomen with gelatinous material, can also produce omental caking and has been studied with advanced imaging techniques to predict its severity.⁷

Non-Cancer Causes That Look the Same on Imaging

Not every omental cake is cancer. This distinction matters because the treatment for tuberculosis of the abdomen and the treatment for ovarian cancer are profoundly different, yet both can produce thickened omentum, ascites, and elevated CA-125 levels. CA-125, a blood marker often used in ovarian cancer workup, can rise in a variety of benign gynecologic conditions, non-gynecologic cancers, and infections.⁸ Tuberculous peritonitis is one of the most important mimics of peritoneal cancer spread, particularly in parts of the world where tuberculosis remains common.

Imaging can offer clues. A PET/CT study comparing tuberculous peritonitis to peritoneal carcinomatosis found that certain patterns differed between the two. In tuberculosis, diffuse metabolic activity in the lesser omentum, an apron-like pattern in the greater omentum, and micronodules smaller than 5 millimeters were more common. In cancer, the classic caked pattern and masses larger than 3 centimeters predominated.⁹ These patterns help, but overlap exists, and tissue biopsy usually remains necessary to confirm the diagnosis.

Symptoms and How Omental Caking Is Discovered

Omental caking itself does not produce a unique set of symptoms. Instead, patients experience the symptoms of whatever underlying disease is causing it. Because the most common cause is advanced abdominal cancer with peritoneal spread, the typical presentation includes increasing abdominal girth from fluid accumulation, bloating, early fullness when eating, and sometimes palpable firmness in the upper abdomen. Many patients are initially evaluated for what they assume is weight gain or digestive trouble.

The finding is most often discovered incidentally on CT scans performed for these symptoms. CT is considered the primary method for evaluating omental diseases, most of which present with nonspecific clinical features that could point to many different conditions.¹⁰ A radiologist looking at the scan sees the normal thin, fatty omentum replaced by a solid, thickened mass sitting between the anterior abdominal wall and the intestines. Alongside omental caking, peritoneal fluid is present in roughly three-quarters of cases, and peritoneal thickening with enhancement appears in about two-thirds.³

Making the Diagnosis Beyond CT

CT identifies the cake, but it cannot always tell you what it is made of. MRI can add useful information. A study comparing malignant omental caking to benign omental thickening on MRI found that certain features strongly favored malignancy: bright signal on diffusion-weighted imaging, contrast enhancement, a convex outer omental contour, and discrete omental nodules. In that study, bright diffusion signal and contrast enhancement were seen in the vast majority of malignant cases and in none of the benign ones.¹¹ These MRI features can be reassuring or alarming, but tissue sampling usually clinches the answer.

Percutaneous biopsy, where a needle is guided through the abdominal wall into the omental mass under image guidance, has become a standard approach. A large single-institution series found that ultrasound-guided omental biopsy was safe and effective for tissue diagnosis, even though omental disease often appears on ultrasound as diffuse thickening without a clearly defined target. Biopsy was diagnostic in most cases when guided by CT landmarks identified beforehand.¹² Another study of image-guided percutaneous omental and mesenteric biopsies reported a technical success rate of 100 percent for omental biopsies, with core biopsies achieving a diagnostic yield of about 99 percent and fine-needle aspiration reaching about 88 percent.¹³ Core biopsy retrieves a small cylinder of tissue rather than just individual cells, which gives pathologists more architecture to work with and generally leads to more definitive diagnoses.

Treatment Depends Entirely on the Cause

There is no treatment for omental caking itself, only for whatever disease has caused it. If the cause is tuberculous peritonitis, standard anti-tuberculosis drug regimens can resolve the omental thickening over months. If the cause is cancer, treatment is more complex and depends on the cancer type, extent of spread, and the patient’s overall health.

For ovarian cancer, the most common scenario, the standard approach involves cytoreductive surgery (also called debulking), where the surgeon removes as much visible tumor as possible, often including the omentum. The goal is to leave behind no residual disease. The presence of an omental cake makes this harder. Research on advanced-stage ovarian cancer has shown that the rate of complete cytoreduction drops significantly when an omental cake is present compared to when it is not.¹⁴ Complete removal of all visible disease is one of the strongest predictors of long-term survival in ovarian cancer, so when the cake is too extensive or involves structures that cannot be safely resected, the surgical team may recommend chemotherapy first to shrink the disease before attempting surgery.

This strategy, called neoadjuvant chemotherapy followed by interval debulking, has become widely accepted when upfront complete surgery seems unlikely. For other cancers, the same principle applies: reduce the tumor burden enough to make surgery feasible. In one reported case, a patient with advanced gastric cancer and extensive peritoneal spread, including omental caking, received systemic chemotherapy with a fluorouracil-based regimen. After 12 cycles, imaging showed marked reduction of the omental and peritoneal lesions and ascites. She then underwent total gastrectomy along with cytoreductive surgery and heated intraperitoneal chemotherapy. Pathology showed only a tiny residual focus of cancer in the stomach and no remaining peritoneal tumor, and the patient remained disease-free for more than four years.¹⁵

Heated Intraperitoneal Chemotherapy

Cytoreductive surgery is often combined with hyperthermic intraperitoneal chemotherapy, commonly abbreviated HIPEC. During HIPEC, heated chemotherapy solution is circulated directly through the abdominal cavity for about an hour immediately after the surgeon removes all visible disease. The heat enhances drug penetration into residual microscopic cancer cells, and delivering the drug directly to the peritoneal surface means the tissue gets far higher drug concentrations than systemic intravenous chemotherapy could achieve. HIPEC is most established for appendiceal cancers with peritoneal spread and has shown benefit in selected patients with ovarian, gastric, and colorectal peritoneal disease. The gastric cancer case described above is an example of how this technique is used alongside systemic therapy and surgery.

Newer intraperitoneal delivery methods are also being explored. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) converts the chemotherapy drug into a fine mist that is sprayed throughout the abdominal cavity during a minimally invasive procedure. Case reports have described PIPAC being used in patients with malignant peritoneal mesothelioma who were initially not candidates for surgery, with the aim of shrinking disease enough to allow cytoreductive surgery later.⁶ These emerging approaches are still being studied in clinical trials and are not yet standard practice for most patients.

What Omental Caking Means for Prognosis

The presence of omental metastasis is an ominous finding in ovarian cancer. In a study of patients with stage III and IV epithelial ovarian cancer, those with confirmed omental metastasis had a five-year overall survival rate of about 43 percent, compared to roughly 94 percent in those without omental involvement. Multivariate analysis in that study found that omental metastasis was an independent risk factor for worse survival, with a hazard ratio just under nine. Patients with omental involvement also responded less well to chemotherapy when the cancer recurred: overall response rates to retreatment were about 32 percent in the omental metastasis group versus about 86 percent in those without it.¹⁶

These numbers reflect the reality that omental caking is a marker of advanced disease, not merely an isolated anatomic finding. The cake signals that cancer cells have already found a way to spread throughout the peritoneal cavity, which generally means the disease is harder to eradicate and more likely to come back. That said, prognosis varies widely depending on the tumor type, how much disease can be surgically removed, and how well the cancer responds to chemotherapy. Outcomes for appendiceal tumors with peritoneal spread, for example, tend to be considerably better than for pancreatic cancer with the same extent of spread.

Palliative and Supportive Care in Advanced Disease

When omental caking is associated with cancer that has progressed beyond what surgery and chemotherapy can control, the focus shifts to symptom management and quality of life. The most burdensome symptom in many patients is recurrent ascites, the fluid that accumulates in the abdomen and causes distension, discomfort, and difficulty breathing. Drainage procedures can be repeated as needed, and in some cases an indwelling catheter is placed so fluid can be drained at home without repeated hospital visits.

As the disease reaches its terminal phase, care goals may shift entirely toward comfort. In one documented case of recurrent high-grade serous ovarian carcinoma, a patient whose disease had progressed despite multiple lines of treatment was enrolled in a home-based hospice program after her functional status declined to the point where further anticancer treatment was inappropriate. Symptoms were managed with subcutaneous morphine, antiemetics, and anxiolytic medications. Following shared decision-making with the family, artificial nutrition, feeding tubes, and tracheostomy were not initiated, consistent with evidence-based end-of-life care principles.¹⁷ Palliative care teams play an increasingly prominent role in managing patients with advanced peritoneal disease, and early involvement of these teams, even while active treatment continues, has been associated with better symptom control and quality of life in many cancer types.

Common Misconceptions Worth Clearing Up

One persistent misunderstanding is that omental caking is a diagnosis. It is not. It is a descriptive finding on imaging or at surgery, much like saying a bone is fractured. The real diagnosis is whatever caused the cake, whether cancer, infection, or another inflammatory condition. Treating the finding without identifying the cause would be like putting a cast on a leg without determining what broke it.

Another misconception is that omental caking always means cancer is inoperable. While its presence does complicate surgery and lowers the likelihood of complete cytoreduction in ovarian cancer, many patients with omental cakes do undergo successful debulking. Neoadjuvant chemotherapy can convert some initially unresectable cases into operable ones. The cake is a challenge, not necessarily a stop sign.

Finally, some patients worry that the omentum is a vital organ whose removal will cause major problems. Omentectomy is a routine part of many abdominal cancer surgeries, and living without an omentum is well tolerated. Patients may lose some of the tissue’s immune surveillance and wound-healing properties, but these functions can be partially compensated for by other peritoneal structures and the broader immune system. The main consequence of omentectomy in practice is that the protective fatty curtain is gone, which can make subsequent abdominal surgeries slightly more prone to adhesion formation between organs and the abdominal wall.